Hyung Ah Jo, Dong Ki Kim, Seokwoo Park, Yaerim Kim, Seung Seok Han, Bo Ram Yang, So-Hyun Choi, Mi-Sook Kim, Joongyub Lee, Hajeong Lee, Jung Pyo Lee, Chun Soo Lim, Yon Su Kim, Kwon Wook Joo
BACKGROUND: Given the cardiovascular risk of nonsteroidal anti-inflammatory drugs (NSAIDs), it is essential to identify the relationship between NSAIDs and cardiovascular outcomes in dialysis patients who have elevated cardiovascular risk. METHODS: A case-crossover study was conducted to assess the association of NSAIDs with major adverse cardiac and cerebrovascular events (MACCEs) and mortality using the Korean Health Insurance dataset. The case period was defined as 1-30 days prior to the event date and the control periods were defined as 61-90 days and 91-120 days prior to the event date...
April 26, 2021: Nephrology, Dialysis, Transplantation